Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

Share Price Information for Abrdn Di&g (ADIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.20
Bid: 77.20
Ask: 78.60
Change: 0.00 (0.00%)
Spread: 1.40 (1.813%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 77.20
ADIG Live PriceLast checked at -
Aberdeen Diversified Income & Growth is an Investment Trust

To target a total portfolio return of LIBOR (London Interbank Offered Rate) plus 5.5% p.a. (net of fees) over rolling five-year periods through investments from the widest range of asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Aberdeen Diversified Income Trust

17 Mar 2020 17:15

RNS Number : 5277G
Aberdeen Diversified I&G Trust PLC
17 March 2020
 

 

London, UK, 17 March 2020

Edison issues review on Aberdeen Diversified Income and Growth Trust (ADIG)

Aberdeen Diversified Income and Growth Trust (ADIG) aims to generate attractive long-term income and capital returns from its diversified multi-asset portfolio. In line with the March 2017 strategy change, the process of recycling capital from listed to longer-term, unlisted holdings is continuing. These should represent c 43% of NAV (vs 26% at end-September 2019) on full deployment of existing commitments. ADIG's underperformance since the strategy change reflects, among other things, ongoing portfolio repositioning, issues with its insurance-linked and litigation finance holdings and the value bias of its listed equity exposure. Since end-May 2019, the discount to NAV has been above the targeted 5%. That said, ADIG outperformed its benchmark over the last 12 months and it continues to offer an attractive prospective dividend yield of c 5.6%.

 

Since the strategy change in March 2017, ADIG's NAV TR performance has lagged its benchmark (Libor + 5.5%), which has resulted in a NAV discount in excess of 5% in recent months. Over the 12 months to January 2020, the NAV TR of 7.5% was ahead of the benchmark, aided by the solid performance of emerging market bonds and asset-backed securities. The last 12 months (LTM) dividend yield of 5.5% is ahead of most of its peers.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Milosz Papst, +44 (0) 20 3077 5700

investmenttrustss@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGPUGGWUPUGMM
Date   Source Headline
27th Nov 202312:46 pmRNSGearing disclosure
27th Nov 202312:02 pmRNSNet Asset Value(s)
24th Nov 202312:14 pmRNSNet Asset Value(s)
23rd Nov 202311:45 amRNSNet Asset Value(s)
22nd Nov 20232:48 pmRNSNet Asset Value(s)
21st Nov 202312:10 pmRNSNet Asset Value(s)
20th Nov 20232:35 pmRNSGearing disclosure
20th Nov 202312:30 pmRNSNet Asset Value(s)
17th Nov 202311:30 amRNSNet Asset Value(s)
16th Nov 202312:20 pmRNSNet Asset Value(s)
15th Nov 202311:56 amRNSNet Asset Value(s)
14th Nov 202312:40 pmRNSNet Asset Value(s)
14th Nov 202312:21 pmRNSPortfolio disclosure
13th Nov 20234:38 pmRNSGearing disclosure
13th Nov 202312:26 pmRNSNet Asset Value(s)
10th Nov 202312:13 pmRNSNet Asset Value(s)
9th Nov 202312:18 pmRNSNet Asset Value(s)
8th Nov 202311:29 amRNSNet Asset Value(s)
7th Nov 202312:28 pmRNSNet Asset Value(s)
6th Nov 20235:07 pmRNSMonth End Net Asset Value(s)
6th Nov 20232:24 pmRNSGearing disclosure
6th Nov 20231:07 pmRNSNet Asset Value(s)
3rd Nov 202312:36 pmRNSNet Asset Value(s)
2nd Nov 202311:49 amRNSNet Asset Value(s)
31st Oct 202312:48 pmRNSNet Asset Value(s)
30th Oct 20232:54 pmRNSGearing disclosure
30th Oct 202311:59 amRNSNet Asset Value(s)
27th Oct 202312:09 pmRNSNet Asset Value(s)
27th Oct 20237:00 amRNSCompliance with Market Abuse Regulation
26th Oct 202312:48 pmRNSNet Asset Value(s)
26th Oct 202310:09 amRNSDirector/PDMR Shareholding
26th Oct 20237:00 amRNSConclusion of Strategic Review
25th Oct 202312:25 pmRNSNet Asset Value(s)
24th Oct 202312:23 pmRNSNet Asset Value(s)
23rd Oct 20234:14 pmRNSDirector/PDMR Shareholding
23rd Oct 202312:46 pmRNSGearing disclosure
23rd Oct 202311:38 amRNSNet Asset Value(s)
20th Oct 20232:38 pmRNSDirector/PDMR Shareholding
20th Oct 202311:56 amRNSNet Asset Value(s)
19th Oct 202312:06 pmRNSNet Asset Value(s)
18th Oct 202312:00 pmRNSNet Asset Value(s)
17th Oct 202311:12 amRNSNet Asset Value(s)
16th Oct 20232:27 pmRNSGearing disclosure
16th Oct 20231:11 pmRNSNet Asset Value(s)
13th Oct 20235:12 pmRNSPortfolio disclosure
13th Oct 202311:42 amRNSNet Asset Value(s)
12th Oct 202311:47 amRNSNet Asset Value(s)
11th Oct 202311:38 amRNSNet Asset Value(s)
10th Oct 202312:56 pmRNSNet Asset Value(s)
9th Oct 20232:41 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.